Scope of Pharma Track and Trace Solution

 

Lowering counterfeit medicines is one benefit of incorporating track and trace mechanisms into pharmaceutical supply chains. Pharmaceutical items are tracked and traced across the supply chain from manufacturer to distributor to dispenser using track and trace systems: serialization or assigning a unique serial number to individual items or commercial units. Aids regulators and pharmaceutical companies determine the location of a drug product or retrospectively identify and verify a drug product's path travelled to determine its authenticity. Pharmaceutical serialization and track-and-trace legislation are primarily intended to combat medicine counterfeiting and theft while improving public health and safety.

Track and trace systems ensure the pharmaceutical supply chain is as secure as possible by providing information about the origin and locations of certain products. This allows regulatory bodies to govern the safe distribution of drugs by reducing the number of counterfeit medicines, making recalls easier and improving logistic management.

By giving information on the origin and location of specific products, track and trace systems ensure that the pharmaceutical supply chain is as secure as feasible. By reducing the number of counterfeit medicines, making recalls easier, and enhancing logistic management; regulatory organizations can better regulate the safe distribution of drugs.

Track and Trace Solution

"Traceability" refers to identifying the source and various stages of consumer product production and distribution processes. Traceability is also known as "track and trace," It relates to the ability to track a product's location across the distribution system at any given time. For years, medical device manufacturers have included "traceability" into their manufacturing processes, allowing each stage of the process, from raw material acquisition to final goods, to be tracked.

Typically, this form of traceability is done on a batch/lot basis. The identification of the production batch or serial number on the primary/immediate and secondary/outer packaging, which is sometimes mentioned in the accompanying commercial documentation, is reinforced in the case of medical products. On the other hand, batch/lot level traceability does not allow for the unambiguous identification of individual units of those batches inside the distribution system. The law that allows a traceability system usually determines the extent of the system.